Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Terminated1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT02051218Phase 3Terminated
Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks
Bone MetastasesMetastatic Breast CancerMetastatic Prostate Cancer
StudychairStart date: 2014-07-16

Research Network

Collaboration Network

6 collaborators·8 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Kantonsspital Winterthur KSW

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Silke Gillessen, Prof

Cantonal Hospital of St. Gallen

Moderately Similar
4 trials

Shared therapeutic areas:

Bone MetastasesMetastatic Breast CancerMetastatic Prostate Cancer

Worked with same sponsors:

Swiss Cancer Institute
Collaborated on 1 trial
Similarity Score34%

Roger von Moos, PD MD

Kantonsspital Graubünden

Moderately Similar
1 trials

Shared therapeutic areas:

Bone MetastasesMetastatic Breast CancerMetastatic Prostate Cancer

Worked with same sponsors:

Swiss Cancer Institute
Collaborated on 1 trial
Similarity Score34%

Arnoud Templeton, MD

Cantonal Hospital of St. Gallen

Moderately Similar
2 trials

Shared therapeutic areas:

Bone MetastasesMetastatic Breast CancerMetastatic Prostate Cancer

Worked with same sponsors:

Swiss Cancer Institute
Collaborated on 1 trial
Similarity Score34%

Xichun Hu, MD, PhD

Fudan University

Related
14 trials

Shared therapeutic areas:

Metastatic Breast CancerBone Metastases
Similarity Score20%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Metastatic Breast CancerMetastatic Prostate Cancer
Similarity Score20%

Ingrid Mayer, MD

Vanderbilt-Ingram Cancer Center

Related
13 trials

Shared therapeutic areas:

Metastatic Breast Cancer
Similarity Score10%

Scott Holden, M.D.

Genentech, Inc.

Related
8 trials

Shared therapeutic areas:

Metastatic Breast Cancer
Similarity Score10%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Metastatic Breast Cancer
Similarity Score10%

Neeta Pandit-Taskar, MD

Memorial Sloan Kettering Cancer Center

Related
8 trials

Shared therapeutic areas:

Metastatic Prostate Cancer
Similarity Score10%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Metastatic Prostate Cancer
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02051218Phase 3StudyChair

Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks

Bone MetastasesMetastatic Breast CancerMetastatic Prostate Cancer
Terminated

All 1 trials loaded